SCHOTT Pharma AG & Co KgaA
SCHOTT Pharma AG & Co's GHG Emissions Data Preview
In 2025, SCHOTT Pharma AG & Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
SCHOTT Pharma AG & Co has also provided a category-level breakdown for 12 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  b | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. b | 0000000 |
Location-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature.  b | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  b | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind SCHOTT Pharma AG & Co’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SCHOTT Pharma AG & Co’s data sources below and access millions more through our Disclosure Search.
Insights into SCHOTT Pharma AG & Co's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of SCHOTT Pharma AG & Co amounted to 74,369 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of SCHOTT Pharma AG & Co increased by 4.05%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
SCHOTT Pharma AG & Co's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are SCHOTT Pharma AG & Co's Scope 1 emissions?
In 2025, the total Scope 1 emissions of SCHOTT Pharma AG & Co were 29,773 metric tons of CO₂ equivalent (tCO₂e).a
Has SCHOTT Pharma AG & Co reduced its Scope 1 emissions over time?
Since 2023, SCHOTT Pharma AG & Co's Scope 1 emissions have decreased by 1.5%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2024), SCHOTT Pharma AG & Co's Scope 1 emissions increased by 8.12%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
What are SCHOTT Pharma AG & Co's Scope 2 emissions?
In 2025, SCHOTT Pharma AG & Co reported Scope 2 greenhouse gas (GHG) emissions of 0 tCO₂e using the market-based method and 44,596 tCO₂e using the location-based method.a
Has SCHOTT Pharma AG & Co reduced its Scope 2 emissions over time?
Since 2023, SCHOTT Pharma AG & Co's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have remained relatively stable, indicating that SCHOTT Pharma AG & Co's emissions have plateaued with no significant change in its energy consumption footprint.ab
Compared to the previous year (2024), SCHOTT Pharma AG & Co's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that SCHOTT Pharma AG & Co's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does SCHOTT Pharma AG & Co use for Scope 2 reporting?
In 2025, SCHOTT Pharma AG & Co reported its Scope 2 emissions using the market-based method and using the location-based method.a
SCHOTT Pharma AG & Co's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into SCHOTT Pharma AG & Co's Value Chain Emissions
In 2025, SCHOTT Pharma AG & Co reported 412,948 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of SCHOTT Pharma AG & Co includes a breakdown across 12 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
SCHOTT Pharma AG & Co's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are SCHOTT Pharma AG & Co's Scope 3 emissions?
In 2025, SCHOTT Pharma AG & Co reported total Scope 3 emissions of 412,948 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 71.58% of these emissions originated from upstream activities such as purchased goods and capital goods, while 28.42% came from downstream activities like product use, distribution, and end-of-life treatment.a
Has SCHOTT Pharma AG & Co reduced its Scope 3 emissions over time?
Since 2023, SCHOTT Pharma AG & Co's Scope 3 emissionshave remained relatively stable, indicating that SCHOTT Pharma AG & Co's emissions have plateaued with no significant change in its value chain footprint.ab
Compared to the previous year (2024), SCHOTT Pharma AG & Co's Scope 3 emissions remained relatively stable, indicating that SCHOTT Pharma AG & Co's emissions have plateaued with no significant change in its value chain footprint.a
What categories of Scope 3 emissions does SCHOTT Pharma AG & Co disclose?
In 2025, SCHOTT Pharma AG & Co reported emissions for 12 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of SCHOTT Pharma AG & Co's Scope 3 emissions?
In 2025, the largest contributors to SCHOTT Pharma AG & Co's Scope 3 emissions were:a
- Purchased Goods and Services (Cat. 1): 220,305 tCO₂e (53.35%)
- Processing of Sold Products (Cat. 10): 67,492 tCO₂e (16.34%)
- Investments (Cat. 15): 33,418 tCO₂e (8.09%)
SCHOTT Pharma AG & Co's Scope 3 Emissions by Categories
Insights into SCHOTT Pharma AG & Co’s GHG Emissions Intensity Compared to Industry Peers
In 2025, SCHOTT Pharma AG & Co reported Scope 1 greenhouse gas (GHG) emissions of 29,773 tCO₂e and total revenues of USD 1,157 millions. This translates into an emissions intensity of 25.73 tCO₂e per millions USD.a
SCHOTT Pharma AG & Co's Scope 1 Emissions Intensity Compared to Peers
How does SCHOTT Pharma AG & Co's GHG emissions intensity compare to its peers?
In 2025, SCHOTT Pharma AG & Co reported a Scope 1 emissions intensity of 25.73 tCO₂e per millions USD. Compared to the peer group median of 4.26, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does SCHOTT Pharma AG & Co rank on GHG emissions intensity within its industry?
In 2025, SCHOTT Pharma AG & Co ranked 23 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places SCHOTT Pharma AG & Co among the least efficient performers, with one of the highest emissions intensities in its sector.a
Insights into SCHOTT Pharma AG & Co's Total Carbon Footprint
In 2025, SCHOTT Pharma AG & Co reported a total carbon footprint of 487,317 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 3.86% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to SCHOTT Pharma AG & Co's total carbon footprint was Scope 3 emissions, accounting for 84.74% of the company's total carbon footprint, followed by Scope 2 emissions at 9.15%.a